2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …

V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review

P Nandhini, P Kumar, S Mickymaray, AS Alothaim… - Antibiotics, 2022 - mdpi.com
Staphylococcus aureus (S. aureus) is a Gram-positive bacterium that may cause life-
threatening diseases and some minor infections in living organisms. However, it shows …

Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the …

LM Baddour, WR Wilson, AS Bayer, VG Fowler Jr… - Circulation, 2015 - Am Heart Assoc
Background—Infective endocarditis is a potentially lethal disease that has undergone major
changes in both host and pathogen. The epidemiology of infective endocarditis has become …

2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology …

G Habib, P Lancellotti, MJ Antunes… - European heart …, 2015 - academic.oup.com
LRRC4 is a novel relatively specific gene, which displays significant down-regulation in
primary brain tumor biopsies and has the potential to suppress brain tumor growth. In this …

Clinical management of Staphylococcus aureus bacteremia: a review

TL Holland, C Arnold, VG Fowler - Jama, 2014 - jamanetwork.com
Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

Predictors of mortality in Staphylococcus aureus bacteremia

SJ Van Hal, SO Jensen, VL Vaska… - Clinical microbiology …, 2012 - Am Soc Microbiol
Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and …

C Liu, A Bayer, SE Cosgrove, RS Daum… - Clinical infectious …, 2011 - academic.oup.com
To clarify whether apoptosis is involved in the injury processes induced by autoantibody
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …

[PDF][PDF] Treatment of methicillin-resistant Staphylococcus aureus bacteremia

EJ Choo, HF Chambers - Infection & chemotherapy, 2016 - synapse.koreamed.org
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-
associated infections. Vancomycin remains an acceptable treatment option. There has been …

Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

GE Thwaites, V Gant - Nature reviews microbiology, 2011 - nature.com
Staphylococcus aureus bacteraemia remains very difficult to treat, and a large proportion of
cases result in potentially lethal metastatic infection. Unpredictable and persistent …

Clinical management of Staphylococcus aureus bacteraemia

GE Thwaites, JD Edgeworth… - The Lancet infectious …, 2011 - thelancet.com
Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …